je.st
news
Tag: therapy
Veterinary Diode Laser is used for surgery and pain therapy.
2013-11-11 14:29:27| Industrial Newsroom - All News for Today
With 9 W of constant power, Pilot™ Diode Laser includes pain therapy hand piece, designed to stimulate circulation and ease pain, as well as surgical hand piece for surgical procedures. Fixed (permanent) fiber cartridge features flexibility that promotes adaptable positioning, fostering maneuverability and navigation during use. In surgical procedures, use avoids bleeding, swelling, infection, and pain associated with scalpel use. Hand pieces are fully interchangeable. This story is related to the following:Health, Medical and Dental Supplies and EquipmentSearch for suppliers of: Surgical Lasers
Tags: pain
therapy
laser
surgery
Merck Receives Breakthrough Therapy Designation for MK-5172/MK-8742, an Investigational Oral Combination Regimen for the Treatment of Chronic Hepatitis C Virus (HCV) Infection
2013-10-22 23:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has granted MK-5172/MK-8742 Breakthrough Therapy designation for treatment of chronic hepatitis C virus infection. MK-5172/MK-8742 is an all-oral combination regimen consisting of MK-5172, an investigational HCV NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor. Language: English Contact: MerckMedia Contacts:Pamela Eisele, 908-423-5042Sarra Herzog, 908-423-6154orInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: treatment
combination
therapy
virus
Results of Phase II PRECEDENT Trial for Investigational Folate Receptor Therapy Vintafolide in Patients with Platinum-Resistant Ovarian Cancer Published in Journal of Clinical Oncology
2013-10-14 23:02:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION N.J., & WEST LAFAYETTE, Ind. Merck and Endocytes Phase III PROCEED pivotal trial of vintafolide in ovarian cancer ongoing WHITEHOUSE STATION N.J., & WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology. Language: English Contact: MerckMedia:Caroline Lappetito,267-305-7639Caroline.Lappetito@Merck.comorClaire Mulhearn, 908-423-7425Claire.Mulhearn@Merck.comorInvestors:Carol Ferguson, 908-423-4465Carol.Ferguson@Merck.comorJustin Holko, 908-423-5088Justin_Holko@Merck.comorEndocyteMedia:Tony Russo, 212-845-4251Tony.Russo@Russopartnersllc.comorMartina Schwarzkopf, 212-845-4292Martina.Schwarzkopf@Russopartnersllc.comorInvestors:Stephanie Ascher, 212-362-1200Stephanie@sternir.com Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: ECYT Exchange: NASDAQ read more
Tags: of
results
journal
published
Mitsubishi Electric to Install Proton Beam Therapy System at New...
2013-10-09 07:43:24| Electronics - Topix.net
Mitsubishi Electric Corporation announced today that it will provide its innovative proton beam therapy system for cancer treatment to the Hakuhokai Group healthcare organization led by Chairman Motohisa Kojo in Osaka, Japan.
Tags: new
system
electric
install
Mitsubishi Electric to Install Proton Beam Therapy System at Tsuyama Chuo Hospital in Okayama, Japan
2013-10-01 07:01:08| Electronics - Topix.net
Mitsubishi Electric Corporation announced today that it has signed an agreement to provide its proprietary proton beam therapy system for cancer treatment to Tsuyama Chuo Hospital, led by Yoshinori Ukita, president of Tsuyama Jifu Group, in Okayama.
Tags: system
japan
hospital
electric
Sites : [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] next »